Skip to main content
Skip to navigation

All Malawi-Liverpool Wellcome Trust (MLW) Clinical Research Programme articles

News
Single dose typhoid conjugate vaccine (TCV) provides lasting efficacy in children

2024-01-25T23:30:00Z

A single dose of the typhoid conjugate vaccine, Typbar TCV®, provides lasting efficacy in preventing typhoid fever in children ages 9 months to 12 years old, according to a new study.